With over 0.47 million Phreesia Inc (PHR) shares trading Friday and a closing price of $24.15 on the day, the dollar volume was approximately $11.42 million. The shares have shown a negative half year performance of -28.38% and its price on 01/12/24 gained nearly 0.96%. Currently, there are 53.22M common shares owned by the public and among those 52.06M shares have been available to trade.
Insiders at the company have transacted a total of 168 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 60 of these insider trades were purchases, accounting for 600,013 shares. Insider sales of the common stock occurred on 108 occasions, with total insider shares sold totaling 347,540 shares.
Shares of Phreesia Inc (NYSE: PHR) opened at $24.11, up $0.19 from a prior closing price of $23.92. However, the script later moved the day high at 24.62, up 0.96%. The company’s stock has a 5-day price change of 8.25% and 45.31% over the past three months. PHR shares are trading 4.32% year to date (YTD), with the 12-month market performance down to -30.92% lower. It has a 12-month low price of $12.05 and touched a high of $40.00 over the same period. PHR has an average intraday trading volume of 704.43K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.10%, 29.59%, and -3.99% respectively.
Institutional ownership of Phreesia Inc (NYSE: PHR) shares accounts for 95.30% of the company’s 53.22M shares outstanding.
It has a market capitalization of $1.34B and a beta (3y monthly) value of 0.95. The earnings-per-share (ttm) stands at -$2.68. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.25% over the week and 5.15% over the month.
Analysts forecast that Phreesia Inc (PHR) will achieve an EPS of -$0.26 for the current quarter, -$0.16 for the next quarter and -$0.36 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.29 while analysts give the company a high EPS estimate of -$0.24. Comparatively, EPS for the current quarter was -$0.43 a year ago. Earnings per share for the fiscal year are expected to increase by 25.01%, and 41.11% over the next financial year.
Looking at the support for the PHR, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on January 03, 2024, with the firm’s price target at $29.
